Page last updated: 2024-08-24

norelgestromin and ethisterone

norelgestromin has been researched along with ethisterone in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's39 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, LS; Anderson, NJ; Leese, PT; Skee, DM; Wong, FA1
Abrams, LS; Creasy, GW; Fisher, AC1
Abrams, LS; Creasy, GW; Leese, PT; Natarajan, J; Shangold, MM; Skee, DM; Wong, FA1
Zieman, M1
Abrams, LS; Natarajan, J; Skee, D; Wong, FA1
Creasy, GW; Fisher, AC; Guillebaud, J; Shangold, GA; Weisberg, E; Zieman, M1
Creasy, GW; Fisher, AC; Meador, ML; Odlind, V; Shangold, GA; Sibai, BM1
Archer, DF; Bigrigg, A; Creasy, GW; Fisher, AC; Shangold, GA; Smallwood, GH1
Creasy, GW; Fisher, AC; Hedon, B; Mansour, D; Shangold, GA; Zacur, HA1
Abrams, LS; Anderson, GD; Natarajan, J; Skee, DM; Wong, FA1
Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK1
Sicat, BL1
Creasy, GW; Fisher, AC; Hall, N; Shangold, GA1
Caubel, P; Chetrite, GS; Friedman, AJ; Pasqualini, JR; Philippe, JC1
Archer, DF; Creasy, GW; Fisher, AC; Moreau, M; Pierson, RA; Shangold, GA1
Hussar, D1
Henzl, MR; Loomba, PK1
Fanta, M1
Evans, SL; Forinash, AB1
Gaspard, U1
Halpern-Felsher, BL; Irwin, CE; Rubinstein, ML1
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T; Zhong, G1
Logsdon, S; Omar, HA; Richards, J1
Dikov, I; Ivanov, S; Sigridov, I1
Lidegaard, O1
Levine, JP1
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T1
Dunn, K; Flanagan, P; Harel, D; Harel, Z; Riggs, S; Vaz, R1
Fisher, AC; Friedman, AJ; Karvois, DL; Kaunitz, AM; Laguardia, KD; Stewart, FH1
Audet, MC; Bouchard, C; Dattani, D; Dinniwell, J; Horbay, GL; Mawdsley, S; Moreau, M; Weisberg, F1
Bainbridge, JD; Fisher, AC; Friedman, AJ; LaGuardia, KD; LoCoco, JM1
Easthope, SE; Goa, KL; Warner, GT1
Jain, JK; Stanczyk, FZ; White, T1
Wooltorton, E1
Atreja, A; Falcone, T; Harris, CM; Jain, A; Thacker, HL1
Radowicki, S; Skórzewska, K; Szlendak, K1
Szarewski, A1

Reviews

12 review(s) available for norelgestromin and ethisterone

ArticleYear
Transdermal contraception.
    Seminars in reproductive medicine, 2001, Volume: 19, Issue:4

    Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Drug Implants; Drug Interactions; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Pregnancy; Safety

2001
Pharmacokinetic overview of Ortho Evra/Evra.
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes

2002
Ortho Evra, a new contraceptive patch.
    Pharmacotherapy, 2003, Volume: 23, Issue:4

    Topics: Administration, Cutaneous; Animals; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Humans; Norgestrel; Oximes

2003
Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    The Journal of reproductive medicine, 2003, Volume: 48, Issue:7

    Topics: Administration, Cutaneous; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Drug Delivery Systems; Equipment Design; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Ethisterone; Female; Gonadal Steroid Hormones; Humans; Male; Norgestrel; Oximes; Testosterone

2003
[A transdermal form of combined hormonal contraceptives (EVRA)].
    Ceska gynekologie, 2003, Volume: 68, Issue:5

    Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes

2003
New hormonal contraceptives: a comprehensive review of the literature.
    Pharmacotherapy, 2003, Volume: 23, Issue:12

    Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes

2003
Evra--a patch on oral contraception?
    Drug and therapeutics bulletin, 2003, Volume: 41, Issue:12

    Topics: Administration, Cutaneous; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Patient Compliance; Pregnancy; Randomized Controlled Trials as Topic

2003
[Medication of the month. Evra: first contraceptive transdermal patch].
    Revue medicale de Liege, 2003, Volume: 58, Issue:11

    Topics: Administration, Cutaneous; Adult; Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Nausea; Norgestrel; Oximes; Vomiting

2003
[Transdermal contraception--a new beginning].
    Akusherstvo i ginekologiia, 2004, Volume: 43 Suppl 1

    Topics: Administration, Cutaneous; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Skin Absorption

2004
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
    The Journal of family practice, 2004, Volume: 53, Issue:11

    Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health

2004
Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
    Treatments in endocrinology, 2003, Volume: 2, Issue:3

    Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes

2003
Hormonal contraception: recent advances.
    The journal of family health care, 2006, Volume: 16, Issue:2

    Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health

2006

Trials

15 trial(s) available for norelgestromin and ethisterone

ArticleYear
Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:11

    Topics: Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Time Factors

2001
Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:12

    Topics: Adhesiveness; Administration, Cutaneous; Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Exercise; Female; Hot Temperature; Humans; Humidity; Middle Aged; Norgestrel; Oximes

2001
Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstrual Cycle; Norgestrel; Oximes; Pregnancy; Proportional Hazards Models

2002
Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Humans; Middle Aged; Norgestrel; North America; Oximes; Patient Compliance

2002
Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.
    British journal of clinical pharmacology, 2002, Volume: 53, Issue:2

    Topics: Administration, Cutaneous; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Humans; Middle Aged; Norgestrel; Oximes

2002
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
    Contraception, 2003, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone

2003
Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    The Journal of reproductive medicine, 2003, Volume: 48, Issue:3

    Topics: Administration, Cutaneous; Adolescent; Adult; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstrual Cycle; Middle Aged; Norgestrel; Oximes; Reference Values; Time Factors; Triglycerides

2003
Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
    Fertility and sterility, 2003, Volume: 80, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medication Errors; Norgestrel; Ovarian Follicle; Ovulation; Oximes; Progesterone; Ultrasonography

2003
An evaluation of the use of the transdermal contraceptive patch in adolescents.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2004, Volume: 34, Issue:5

    Topics: Administration, Cutaneous; Adolescent; Analysis of Variance; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Humans; Longitudinal Studies; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; San Francisco

2004
Long-term evaluation of the use of the transdermal contraceptive patch in adolescents.
    TheScientificWorldJournal, 2004, Jul-08, Volume: 4

    Topics: Administration, Cutaneous; Adolescent; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethisterone; Female; Humans; Norgestrel; Oximes; Patient Compliance; Time

2004
Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Obstetrics and gynecology, 2005, Volume: 105, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstruation; Middle Aged; Norgestrel; Oximes; Patient Satisfaction

2005
Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2005, Volume: 27, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Condoms; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Intrauterine Devices; Middle Aged; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; Safety; Spermatocidal Agents; Treatment Outcome

2005
Suppression of estrogen-withdrawal headache with extended transdermal contraception.
    Fertility and sterility, 2005, Volume: 83, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Delayed-Action Preparations; Drug Combinations; Ethisterone; Female; Headache; Humans; Middle Aged; Norgestrel; Oximes; Substance Withdrawal Syndrome; Time Factors

2005
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
    American journal of obstetrics and gynecology, 2005, Volume: 192, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome

2005
[Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
    Ginekologia polska, 2005, Volume: 76, Issue:11

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Women's Health

2005

Other Studies

12 other study(ies) available for norelgestromin and ethisterone

ArticleYear
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins

2002
A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Ethisterone; Female; Humans; Middle Aged; Norgestrel; Oximes; Pregnancy

2002
Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions.
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Adhesives; Administration, Cutaneous; Adolescent; Adult; Climate; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Exercise; Female; Hot Temperature; Humans; Humidity; Middle Aged; Norgestrel; Oximes

2002
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:2-3

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethisterone; Humans; Inhibitory Concentration 50; Medroxyprogesterone Acetate; Models, Chemical; Norgestrel; Oximes; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured

2003
New drugs 2003, part II.
    Nursing, 2003, Volume: 33, Issue:7

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Approval; Drug Combinations; Drug Therapy; Epoprostenol; Estradiol; Ethisterone; Filgrastim; Fondaparinux; Fulvestrant; Granulocyte Colony-Stimulating Factor; Humans; Norgestrel; Oximes; Polyethylene Glycols; Polysaccharides; Recombinant Proteins; Triptorelin Pamoate; United States; Vinyl Compounds

2003
New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
    The journal of family planning and reproductive health care, 2004, Volume: 30, Issue:1

    Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Device Approval; Drug Combinations; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; United Kingdom; Women's Health

2004
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Cell Line, Tumor; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Ethisterone; Female; Humans; Matrix Metalloproteinase 2; Norgestrel; Oximes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2

2004
[Hormonal contraceptive patch].
    Ugeskrift for laeger, 2004, Oct-04, Volume: 166, Issue:41

    Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Risk Factors

2004
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 19, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured

2004
Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
    Journal of pediatric and adolescent gynecology, 2005, Volume: 18, Issue:2

    Topics: Abdomen; Acne Vulgaris; Administration, Cutaneous; Adolescent; Attitude to Health; Breast; Buttocks; Condoms; Contraceptives, Oral, Combined; Drug Carriers; Drug Combinations; Dysmenorrhea; Ethisterone; Female; Headache; Humans; Menstrual Cycle; Menstruation; Nausea; Norgestrel; Oximes; Patient Dropouts; Patient Satisfaction

2005
The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Jan-17, Volume: 174, Issue:2

    Topics: Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; United States; United States Food and Drug Administration

2006
How should we advise patients about the contraceptive patch, given the FDA warning?
    Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:1

    Topics: Contraceptives, Oral, Combined; Counseling; Drug Combinations; Drug Utilization; Ethisterone; Female; Humans; Norgestrel; Oximes; Physician-Patient Relations; Practice Patterns, Physicians'; Risk Assessment; United States; United States Food and Drug Administration; Venous Thrombosis

2006